Framingham, MA, United States of America

Linda Marie Strange

This inventor holds 3 USPTO granted patents. Top assignee: Takeda Vaccines, Inc.. Active years: 2020-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Linda Marie Strange. Retrieved from https://idiyas.com/inventor/linda-marie-strange

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 66.7

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2020-2026

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Linda Marie Strange: Innovator in Flavivirus Stabilization

Introduction

Linda Marie Strange is a notable inventor based in Framingham, MA (US). She has made significant contributions to the field of virology, particularly in the stabilization of flaviviruses. With a total of 3 patents to her name, her work is crucial for advancements in vaccine development.

Latest Patents

Linda's latest patents focus on compositions and methods for stabilizing flaviviruses with improved formulations. These embodiments relate to stabilizing live, attenuated, or unattenuated flaviviruses. The patents also address methods for reducing degradation of these viruses and improving formulations for prolonging their stabilization during manufacturing, storage, and transport. Additionally, her work includes the development of kits for transportable applications and methods.

Career Highlights

Linda Marie Strange is currently employed at Takeda Vaccines, Inc., where she continues to innovate in the field of vaccine research. Her expertise in stabilizing flaviviruses has positioned her as a key player in the development of effective vaccines.

Collaborations

Some of her notable coworkers include Jill Ann Livengood and Steven Michael Erb. Their collaborative efforts contribute to the ongoing research and development in the field of virology.

Conclusion

Linda Marie Strange's contributions to the stabilization of flaviviruses are vital for the advancement of vaccine technology. Her innovative work at Takeda Vaccines, Inc. continues to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…